Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hongyi Zhou
Georgia Institute of Technology, Department: Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
PanXome
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The Committee determined that Dr. Zhou has a Financial Conflict of Interest (FCOI) on this project because he has a significant financial interest in the licensee of the technologies being studied. His financial interest in the technologies being studied and in PanXome could bias or appear to bias the design, conduct, or reporting of this research.
Interplay of inherent promiscuity and specificity in protein biochemical function with applications to drug discovery and exome analysis
In principle, the information provided by the ~228,000 human exomes sequenced this year could provide tremendous insights into personalized disease diagnosis and treatment. However, this potential is often unrealized as many genetic variations in an exome are of unknown significance and small molecule therapies to redress the functional effects of the associated disease(s) are unknown. This project will develop the tools needed for a comprehensive approach to exome annotation that will suggest which variations might have significant disease association, what diseases they might cause, and what repurposed drugs might assist in the treatment of the identified disease(s).
Filed on December 05, 2016.
Tell us what you know about Hongyi Zhou's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Hongyi Zhou”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hongyi Zhou | Georgia Institute of Technology | Conflict of Interest | IntelliMedix | $5,000 - $9,999 |
| Hongyi Zhou | Georgia Institute of Technology | Conflict of Interest | PanXome, LLC | |
| Hongyi Zhou | Georgia Institute of Technology | Conflict of Interest | PanXome, LLc | |
| Hongyi Zhou | Georgia Institute of Technology | Conflict of Interest | Intellimedix | Value cannot be readily determined |
| Hongyi Zhou | Georgia Institute of Technology | Conflict of Interest | PanXome, LLC |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.